  A full Bayesian approach to the estimation of Vaccine Efficacy is presented,
which is an improvement over the currently used exact method conditional on the
total number of cases. As an example, we reconsider the statistical sections of
the BioNTech/Pfizer protocol, which in 2020 has led to the first approved
anti-Covid-19 vaccine.
